Shreyansh Shah1, Marie Luby1, Karen Poole1, Teresa Morella1, Elizabeth Keller1, Richard T Benson1, John K Lynch1, Zurab Nadareishvili1, Amie W Hsia2. 1. From the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD. 2. From the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD. amie.hsia@medstar.net.
Abstract
OBJECTIVE: The objective of this study was to demonstrate the feasibility of timely multimodal MRI screening before thrombolysis in acute stroke patients. METHODS: Quality improvement processes were initiated in 2013 to reduce door-to-needle (DTN) time at the 2 hospitals where the NIH stroke team provides clinical care. Acute ischemic stroke (AIS) patients who received IV tissue plasminogen activator (tPA) ≤4.5 hours from last known normal were identified. Demographic and clinical characteristics and timing metrics were analyzed comparing the time periods before, during, and after the quality improvement processes. RESULTS: There were 157 patients treated with IV tPA for AIS during 2012-2013, of whom 135 (86%) were screened with MRI. DTN time was significantly reduced by 40% during this period from a median of 93 minutes in the first half of 2012 to 55 minutes in the last half of 2013 (p < 0.0001) with a significant 4-fold increase in the proportion of treated patients with DTN time ≤60 minutes from 13.0% to 61.5%, respectively (p < 0.00001). Improvement in DTN time was associated with reduced door-to-MRI time, and there were no differences in demographic or clinical characteristics (p = 0.21-0.76). CONCLUSIONS: It is feasible and practical to consistently and rapidly deliver IV tPA to AIS patients within national benchmark times using MRI as the routine screening modality. The processes used in the SMART (Screening with MRI for Accurate and Rapid Stroke Treatment) Study to reduce DTN time have the potential to be widely applicable to other hospitals.
OBJECTIVE: The objective of this study was to demonstrate the feasibility of timely multimodal MRI screening before thrombolysis in acute strokepatients. METHODS: Quality improvement processes were initiated in 2013 to reduce door-to-needle (DTN) time at the 2 hospitals where the NIH stroke team provides clinical care. Acute ischemic stroke (AIS) patients who received IV tissue plasminogen activator (tPA) ≤4.5 hours from last known normal were identified. Demographic and clinical characteristics and timing metrics were analyzed comparing the time periods before, during, and after the quality improvement processes. RESULTS: There were 157 patients treated with IV tPA for AIS during 2012-2013, of whom 135 (86%) were screened with MRI. DTN time was significantly reduced by 40% during this period from a median of 93 minutes in the first half of 2012 to 55 minutes in the last half of 2013 (p < 0.0001) with a significant 4-fold increase in the proportion of treated patients with DTN time ≤60 minutes from 13.0% to 61.5%, respectively (p < 0.00001). Improvement in DTN time was associated with reduced door-to-MRI time, and there were no differences in demographic or clinical characteristics (p = 0.21-0.76). CONCLUSIONS: It is feasible and practical to consistently and rapidly deliver IV tPA to AIS patients within national benchmark times using MRI as the routine screening modality. The processes used in the SMART (Screening with MRI for Accurate and Rapid Stroke Treatment) Study to reduce DTN time have the potential to be widely applicable to other hospitals.
Authors: N Hjort; K Butcher; S M Davis; C S Kidwell; W J Koroshetz; J Röther; P D Schellinger; S Warach; L Østergaard Journal: Stroke Date: 2004-12-23 Impact factor: 7.914
Authors: Julio A Chalela; Chelsea S Kidwell; Lauren M Nentwich; Marie Luby; John A Butman; Andrew M Demchuk; Michael D Hill; Nicholas Patronas; Lawrence Latour; Steven Warach Journal: Lancet Date: 2007-01-27 Impact factor: 79.321
Authors: Gregg C Fonarow; Eric E Smith; Jeffrey L Saver; Mathew J Reeves; Adrian F Hernandez; Eric D Peterson; Ralph L Sacco; Lee H Schwamm Journal: Stroke Date: 2011-09-01 Impact factor: 7.914
Authors: Ronen R Leker; Galina Keigler; Roni Eichel; Tamir Ben Hur; John M Gomori; Jose E Cohen Journal: Int J Stroke Date: 2014-08 Impact factor: 5.266
Authors: P D Schellinger; O Jansen; J B Fiebach; O Pohlers; H Ryssel; S Heiland; T Steiner; W Hacke; K Sartor Journal: AJNR Am J Neuroradiol Date: 2000-08 Impact factor: 3.825
Authors: Cheryl B Lin; Eric D Peterson; Eric E Smith; Jeffrey L Saver; Li Liang; Ying Xian; Daiwai M Olson; Bimal R Shah; Adrian F Hernandez; Lee H Schwamm; Gregg C Fonarow Journal: Circ Cardiovasc Qual Outcomes Date: 2012-07-10
Authors: A Kruetzelmann; S Siemonsen; C Gerloff; M Rosenkranz; J Röther; J Fiehler; G Thomalla Journal: J Neurol Neurosurg Psychiatry Date: 2009-10 Impact factor: 10.154
Authors: Manu S Goyal; Brian G Hoff; Jennifer Williams; Naim Khoury; Rebecca Wiesehan; Laura Heitsch; Peter Panagos; Katie D Vo; Tammie Benzinger; Colin P Derdeyn; Jin-Moo Lee; Andria L Ford Journal: Stroke Date: 2016-02-18 Impact factor: 7.914
Authors: Tina M Burton; Marie Luby; Zurab Nadareishvili; Richard T Benson; John K Lynch; Lawrence L Latour; Amie W Hsia Journal: Neurology Date: 2017-06-28 Impact factor: 9.910
Authors: Shahram Majidi; Marie Luby; John K Lynch; Amie W Hsia; Richard T Benson; Chandni P Kalaria; Zurab Nadareishvili; Lawrence L Latour; Richard Leigh Journal: Neurology Date: 2019-09-13 Impact factor: 9.910
Authors: Ilana M Ruff; Ava L Liberman; Fan Z Caprio; Matthew B Maas; Scott J Mendelson; Farzaneh A Sorond; Deborah Bergman; Richard A Bernstein; Yvonne Curran; Shyam Prabhakaran Journal: Neurol Clin Pract Date: 2017-06
Authors: Francesco Arba; Richard Leigh; Domenico Inzitari; Steven J Warach; Marie Luby; Kennedy R Lees Journal: Neurology Date: 2017-10-25 Impact factor: 9.910